Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001754249-20-000001
Filing Date
2020-02-04
Accepted
2020-02-04 21:16:32
Documents
1
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6745
  Complete submission text file 0001754249-20-000001.txt   8269
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INFINERA CORPORATION 140 CASPIAN COURT SUNNYVALE CA 94089
Business Address
Welch David F (Reporting) CIK: 0001399122 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 20576165